Soccer player Ubogagu banned for unintentional doping breach
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 19/05/2022 (1551 days ago), so information in it may no longer be current.
LONDON (AP) — English soccer player Chioma Ubogagu is serving a nine-month suspension for failing a doping test after medication for a skin condition contained a prohibited substance.
Ubogagu, who scored on her England debut in 2018, joined Women’s Super League team Tottenham last year. She was initially provisionally suspended in January but details of the case and verdict were announced only on Thursday.
Canrenone, a masking agent, was detected in an out-of-competition test in October. It was in anti-acne tablets that Ubogagu had been prescribed by her dermatologist in Texas where she played for the Houston Dash in 2018.
In 2012, then-United States goalkeeper Hope Solo received only a public warning from the United States Anti-Doping Agency after Canrenone was detected in her urine test.
An English Football Association regulatory commission found there were no intentional doping rule breaches by Ubogagu to improve performances and that she was taking the medication for a recognized condition.
“I want to make clear that the medication had no performance-enhancing effects for me, but I still made the mistake of not being as diligent as possible, and as a result I am unable to play the game I love until I serve my suspension,” Ubogagu said in a statement. “While my dermatologist is aware of my profession, it is also my responsibility to know more about the medications I am prescribed.”
Ubogagu can’t play again until October.
___
More AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports